Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Okada

Showing results (841-850 of 1,489) with videos related to

Pageof 149
Sort By:
No to Hattatsu = Brain and Development|January 1, 1994
[Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood]J Tanaka, K Matsuzaki, H Arai, et al.
Journal of Virological Methods|March 20, 1998
Genetic subtyping and epidemiological study of feline immunodeficiency virus by nested polymerase chain reaction-restriction fragment length polymorphism analysis of the gag geneT Hohdatsu, K Motokawa, M Usami, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|January 1, 1997
[Hydrocortisone Acetate Reference Standard (Control 961) of National Institute of Health Sciences]Y Tagashira, A Kitajima, K Maekawa, et al.
The American Journal of Pathology|November 5, 1997
Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridizationH Tsuda, T Takarabe, N Susumu, et al.
Arzneimittel-Forschung|April 29, 1998
Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeysT Konishi, S Okada, H Nishikawa, et al.
Biological & Pharmaceutical Bulletin|May 31, 2001
Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoterK Yamanaka, M Mizol, K Kato, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 1, 1994
[Evaluation of anticoagulant activity for low molecular-weight heparin by chromogenic substrate. Measurement of factor Xa and thrombin activities]S Ishimitsu, T Sugiyama, M Itoh, et al.
Cancer|January 15, 1995
Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agentT Higuchi, S Okada, H Mori, et al.
Biological & Pharmaceutical Bulletin|January 1, 1995
DNA-strand breaks induced by dimethylarsinic acid, a metabolite of inorganic arsenics, are strongly enhanced by superoxide anion radicalsK Rin, K Kawaguchi, K Yamanaka, et al.
Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences|January 1, 1993
[Riboflavin Reference Standard (Control 921) of National Institute of Health Sciences]W Izumi, A Kitajima, K Yoshii, et al.
Pageof 149

Showing results (841-850 of 1,489) with videos related to

Sort By:
Pageof 149
No to Hattatsu = Brain and Development|January 1, 1994
[Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood]J Tanaka, K Matsuzaki, H Arai, et al.
Journal of Virological Methods|March 20, 1998
Genetic subtyping and epidemiological study of feline immunodeficiency virus by nested polymerase chain reaction-restriction fragment length polymorphism analysis of the gag geneT Hohdatsu, K Motokawa, M Usami, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|January 1, 1997
[Hydrocortisone Acetate Reference Standard (Control 961) of National Institute of Health Sciences]Y Tagashira, A Kitajima, K Maekawa, et al.
The American Journal of Pathology|November 5, 1997
Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridizationH Tsuda, T Takarabe, N Susumu, et al.
Arzneimittel-Forschung|April 29, 1998
Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeysT Konishi, S Okada, H Nishikawa, et al.
Biological & Pharmaceutical Bulletin|May 31, 2001
Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoterK Yamanaka, M Mizol, K Kato, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 1, 1994
[Evaluation of anticoagulant activity for low molecular-weight heparin by chromogenic substrate. Measurement of factor Xa and thrombin activities]S Ishimitsu, T Sugiyama, M Itoh, et al.
Cancer|January 15, 1995
Leukemic transformation of polycythemia vera and essential thrombocythemia possibly associated with an alkylating agentT Higuchi, S Okada, H Mori, et al.
Biological & Pharmaceutical Bulletin|January 1, 1995
DNA-strand breaks induced by dimethylarsinic acid, a metabolite of inorganic arsenics, are strongly enhanced by superoxide anion radicalsK Rin, K Kawaguchi, K Yamanaka, et al.
Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences|January 1, 1993
[Riboflavin Reference Standard (Control 921) of National Institute of Health Sciences]W Izumi, A Kitajima, K Yoshii, et al.
Pageof 149